Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Laura Lazo, Iris Valdes, Gerardo Guillén, Lisset Hermida & Lázaro Gil. (2019) Aiming at the heart: the capsid protein of dengue virus as a vaccine candidate. Expert Review of Vaccines 18:2, pages 161-173.
Read now
Read now
Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan & Navin Khanna. (2019) Next generation designer virus-like particle vaccines for dengue. Expert Review of Vaccines 18:2, pages 105-117.
Read now
Read now
Guan-Ling Lin, Hsin-Hou Chang, Te-Sheng Lien, Po-Kong Chen, Hao Chan, Mei-Tzu Su, Chi-Yuan Liao & Der-Shan Sun. (2017) Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis. Virulence 8:8, pages 1719-1731.
Read now
Read now
Ambuj Shrivastava, Nagesh K Tripathi, Paban K. Dash & Manmohan Parida. (2017) Working towards dengue as a vaccine-preventable disease: challenges and opportunities. Expert Opinion on Biological Therapy 17:10, pages 1193-1199.
Read now
Read now
Jian Hang Lam, Li Ching Ong & Sylvie Alonso. (2016) Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates?. Expert Review of Vaccines 15:4, pages 483-495.
Read now
Read now
Vinita Puri, Emily Streaker, Ponraj Prabakaran, Zhongyu Zhu & Dimiter S. Dimitrov. (2013) Highly efficient selection of epitope specific antibody through competitive yeast display library sorting. mAbs 5:4, pages 533-539.
Read now
Read now
Sathyamangalam Swaminathan, Gaurav Batra & Navin Khanna. (2010) Dengue vaccines: state of the art. Expert Opinion on Therapeutic Patents 20:6, pages 819-835.
Read now
Read now
Articles from other publishers (94)
Satpal Singh, Arunima Kumar Verma, Nupoor Chowdhary, Shikha Sharma & Abhishek Awasthi. (2023) Dengue havoc: overview and eco-friendly strategies to forestall the current epidemic. Environmental Science and Pollution Research.
Crossref
Crossref
Veronica de Moraes Manzato, Camila Di Santo, Ricardo Jose Soares Torquato, Camila Coelho, Gloria Gallo, Leon Hardy, Martin Würtele & Aparecida Sadae Tanaka. (2023) Boophilin D1, a Kunitz type protease inhibitor, as a source of inhibitors for the ZIKA virus NS2B-NS3 protease. Biochimie 214, pages 96-101.
Crossref
Crossref
Pashupati Pokharel, Surakshya Khanal, Sagun Ghimire, Kailash M. Pokhrel & Abhigan B. Shrestha. (2023) Frequent outbreaks of dengue in Nepal – causes and solutions: a narrative review. International Journal of Surgery: Global Health 6:5.
Crossref
Crossref
Li-Chen Yen, Hsin-Wei Chen, Chia-Lo Ho, Chang-Chi Lin, Yi-Ling Lin, Qiao-Wen Yang, Kuo-Chou Chiu, Shu-Pei Lien, Ren-Jye Lin & Ching-Len Liao. (2023) Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. Journal of Biomedical Science 30:1.
Crossref
Crossref
Zahid Hussain, Saima Rani, Fanshu Ma, Wenjing Li, Wenqi Shen, Tian Gao, Jine Wang & Renjun Pei. (2023) Dengue determinants: Necessities and challenges for universal dengue vaccine development. Reviews in Medical Virology 33:2.
Crossref
Crossref
Mathurin Seesen, Tuksin Jearanaiwitayakul, Jitra Limthongkul, Panuwat Midoeng, Panya Sunintaboon & Sukathida Ubol. (2023) A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells. Vaccine 41:9, pages 1638-1648.
Crossref
Crossref
Lihong He, Wenqiang Sun, Limin Yang, Wenjun Liu & Jing Li. (2022) A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice. Virologica Sinica 37:5, pages 746-757.
Crossref
Crossref
Mohammad Shoushtari, Ladan Mafakher, Saman Rahmati, Mostafa Salehi-Vaziri, Arash Arashkia, Farzin Roohvand, Ladan Teimoori-Toolabi & Kayhan Azadmanesh. (2022) Designing vaccine candidates against dengue virus by in silico studies on structural and nonstructural domains. Molecular and Cellular Probes 63, pages 101818.
Crossref
Crossref
Rafiq Ahmad Khan, Farhan Ahmed, Sumbul Afroz & Nooruddin Khan. (2022) Tetravalent formulation of polymeric nanoparticle-based vaccine induces a potent immune response against dengue virus. Biomaterials Science 10:11, pages 2917-2928.
Crossref
Crossref
Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, Shuying Wang, Chih-Peng Chang, Tzong-Shiann Ho, Yu-San Kao, Sen-Mao Tien, Hsing-Han Lin, Po-Chun Chang, Yen-Chung Lai, Yu-Peng Hsiao, Yi-Ling Liu, Chiao-Hsuan Chao, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin & Shu-Wen Wan. (2022) A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein. Vaccine 40:15, pages 2299-2310.
Crossref
Crossref
Harun Norshidah, Ramachandran Vignesh & Ngit Shin Lai. (2021) Updates on Dengue Vaccine and Antiviral: Where Are We Heading?. Molecules 26:22, pages 6768.
Crossref
Crossref
Rong Wang, Jiansheng Lu, Lei Chen, Yunzhou Yu & Zhixin Yang. (2021) A human bispecific neutralization antibody against four serotypes of dengue virus. Virology 558, pages 49-56.
Crossref
Crossref
Te-Sheng Lien, Der-Shan Sun, Cheng-Yeu Wu & Hsin-Hou Chang. (2021) Exposure to Dengue Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Endothelial Dysfunction and Hemorrhage in Mice. Frontiers in Immunology 12.
Crossref
Crossref
Henry Puerta-Guardo, Scott B. Biering, Eva Harris, Norma Pavia-Ruz, Gonzalo Vázquez-Prokopec, Guadalupe Ayora-Talavera & Pablo Manrique-Saide. 2020. Dengue Fever in a One Health Perspective. Dengue Fever in a One Health Perspective.
Jennifer L. Remmel, Kathryn S. Beauchemin, Akaash K. Mishra, Julia C. Frei, Jonathan R. Lai, Chris Bailey-Kellogg & Margaret E. Ackerman. (2020) Combinatorial Resurfacing of Dengue Envelope Protein Domain III Antigens Selectively Ablates Epitopes Associated with Serotype-Specific or Infection-Enhancing Antibody Responses. ACS Combinatorial Science 22:9, pages 446-456.
Crossref
Crossref
Sitara Nasar, Naeem Rashid & Saima Iftikhar. (2019) Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti‐dengue treatment: A review. Journal of Medical Virology 92:8, pages 941-955.
Crossref
Crossref
Alice F. Versiani, Estefânia M. N. Martins, Lidia M. Andrade, Laura Cox, Glauco C. Pereira, Edel F. Barbosa-Stancioli, Mauricio L. Nogueira, Luiz O. Ladeira & Flávio G. da Fonseca. (2020) Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections. Scientific Reports 10:1.
Crossref
Crossref
Vipin S. Rana, Sonam Popli, Gunjan K. Saurav, Karuna Yadav, Ankit Kumar, Sujatha Sunil, Narendra Kumar, Om P. Singh, Krishnamurthy Natarajan & Raman Rajagopal. (2020)
Aedes aegypti
lachesin protein binds to the domain III of envelop protein of Dengue virus‐2 and inhibits viral replication
. Cellular Microbiology 22:7.
Crossref
Crossref
Lucas Wilken & Guus F. Rimmelzwaan. (2020) Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?. Pathogens 9:6, pages 470.
Crossref
Crossref
Abhishek Singh Rathore, Animesh Sarker & Rinkoo Devi Gupta. (2020) Production and immunogenicity of Fubc subunit protein redesigned from DENV envelope protein. Applied Microbiology and Biotechnology 104:10, pages 4333-4344.
Crossref
Crossref
Ahmad Husein Alkaff, Mutiara Saragih, Mochammad Arfin Fardiansyah & Usman Sumo Friend Tambunan. (2020) Role of Immunoinformatics in Accelerating Epitope-Based Vaccine Development against Dengue Virus. The Open Biochemistry Journal 14:1, pages 9-18.
Crossref
Crossref
Chung-Lin Tsai, Der-Shan Sun, Mei-Tzu Su, Te-Sheng Lien, Yen-Hsu Chen, Chun-Yu Lin, Chung-Hao Huang, Chwan-Chuen King, Chen-Ru Li, Tai-Hung Chen, Yu-Hsiang Chiu, Chun-Chi Lu & Hsin-Hou Chang. (2020) Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice. Scientific Reports 10:1.
Crossref
Crossref
Julieta Cerezo, Alexandra Marisa Targovnik, María Emilia Smith, Daniel González Maglio, Victoria Celina Luppo, María Alejandra Morales, María Victoria Miranda & Julián Rodríguez Talou. (2019) Simple production of hydrophobin-fused domain III of dengue envelope protein and induction of neutralizing antibodies against the homotypic serotype of dengue virus. Biotechnology Letters 42:3, pages 419-428.
Crossref
Crossref
Viviana C. Zomosa-Signoret, Karina R. Morales-González, Ana E. Estrada-Rodríguez, Ana M. Rivas-Estilla, M. Cristina Devèze-García, Edgar Galaviz-Aguilar & Román Vidaltamayo. (2020) Alanine Substitution Inactivates Cross-Reacting Epitopes in Dengue Virus Recombinant Envelope Proteins. Viruses 12:2, pages 208.
Crossref
Crossref
Sumbul Afroz, ShamaSrikanth Battu, Shaikh MatinSabrina SoloukiJessica P. ElmoreGillipsie MinhasWeishan Huang, Avery August & Nooruddin Khan. (2019) Amino acid starvation enhances vaccine efficacy by augmenting neutralizing antibody production. Science Signaling 12:607.
Crossref
Crossref
Rafiq Ahmad Khan, Sumbul Afroz, Gillipsie Minhas, Srikanth Battu & Nooruddin Khan. (2019) Dengue virus envelope protein domain III induces pro-inflammatory signature and triggers activation of inflammasome. Cytokine 123, pages 154780.
Crossref
Crossref
Stefan W. Metz, Ashlie Thomas, Alex Brackbill, John Forsberg, Michael J. Miley, Cesar A. Lopez, Helen M. Lazear, Shaomin Tian & Aravinda M. de Silva. (2019) Oligomeric state of the ZIKV E protein defines protective immune responses. Nature Communications 10:1.
Crossref
Crossref
Satish N. Dighe, O'mezie Ekwudu, Kamal Dua, Dinesh Kumar Chellappan, Peter L. Katavic & Trudi A. Collet. (2019) Recent update on anti-dengue drug discovery. European Journal of Medicinal Chemistry 176, pages 431-455.
Crossref
Crossref
André Eerde, Johanna Gottschamel, Ralph Bock, Kristine Eraker Aasland Hansen, Hetron Mweemba Munang'andu, Henry Daniell & Jihong Liu Clarke. (2019)
Production of tetravalent dengue virus envelope protein domain
III
based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development
. Plant Biotechnology Journal 17:7, pages 1408-1417.
Crossref
Crossref
Dan Hu, Zhongyu Zhu, Shun Li, Yongqiang Deng, Yanling Wu, Nana Zhang, Vinita Puri, Chunyu Wang, Peng Zou, Cheng Lei, Xiaolong Tian, Yulu Wang, Qi Zhao, Wei Li, Ponraj Prabakaran, Yang Feng, Jane Cardosa, Chengfeng Qin, Xiaohui Zhou, Dimiter S. Dimitrov & Tianlei Ying. (2019) A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III. PLOS Pathogens 15:6, pages e1007836.
Crossref
Crossref
Atsushi Yamanaka & Eiji Konishi. (2019) Key Amino Acid Substitution for Infection-Enhancing Activity-Free Designer Dengue Vaccines. iScience 13, pages 125-137.
Crossref
Crossref
Stephan T Kudlacek & Stefan W Metz. (2019) Focused dengue vaccine development: outwitting nature's design. Pathogens and Disease 77:1.
Crossref
Crossref
Julieta Cerezo, María Emilia Smith & Julián Rodríguez Talou. (2019) In situ removal of consensus dengue virus envelope protein domain III fused to hydrophobin in Pichia pastoris cultures. Protein Expression and Purification 153, pages 131-137.
Crossref
Crossref
Jyotiranjan Bal, Hee-Young Jung, Luong Ngoc Nguyen, Jisang Park, Yong-Suk Jang & Dae-Hyuk Kim. (2018) Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate. Microbial Cell Factories 17:1.
Crossref
Crossref
Jyotiranjan Bal, Nguyen Ngoc Luong, Jisang Park, Ki-Duk Song, Yong-Suk Jang & Dae-Hyuk Kim. (2018) Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate. Microbial Cell Factories 17:1.
Crossref
Crossref
Quang Huy Quach, Swee Kim Ang, Jang-Hann Justin Chu & James Chen Yong Kah. (2018) Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus. Acta Biomaterialia 78, pages 224-235.
Crossref
Crossref
Nagesh K. Tripathi & Ambuj Shrivastava. (2018) Recent Developments in Recombinant Protein–Based Dengue Vaccines. Frontiers in Immunology 9.
Crossref
Crossref
Hossein Fahimi, Mahshid Mohammadipour, Hamed Haddad Kashani, Farshid Parvini & Majid Sadeghizadeh. (2018) Dengue viruses and promising envelope protein domain III-based vaccines. Applied Microbiology and Biotechnology 102:7, pages 2977-2996.
Crossref
Crossref
Scott B. Halstead & Stephen J. Thomas. 2018. Plotkin's Vaccines. Plotkin's Vaccines
241
251.e6
.
Lídia M Andrade, Laura Cox, Alice F Versiani & Flávio G da Fonseca. (2017) A growing world of small things: a brief review on the nanostructured vaccines. Future Virology 12:12, pages 767-779.
Crossref
Crossref
Mi-Young Kim, Craig Van Dolleweerd, Alastair Copland, Matthew John Paul, Sven Hofmann, Gina R. Webster, Emily Julik, Ivonne Ceballos-Olvera, Jorge Reyes-del Valle, Moon-Sik Yang, Yong-Suk Jang, Rajko Reljic & Julian K. Ma. (2017) Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate. Plant Biotechnology Journal 15:12, pages 1590-1601.
Crossref
Crossref
Xingcui Zhang, Renyong Jia, Haoyue Shen, Mingshu Wang, Zhongqiong Yin & Anchun Cheng. (2017) Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections. Viruses 9:11, pages 338.
Crossref
Crossref
Mi-Young Kim, Jing-Ying Li, Nguyen-Quang-Duc Tien & Moon-Sik Yang. (2017) Expression and assembly of cholera toxin B subunit and domain III of dengue virus 2 envelope fusion protein in transgenic potatoes. Protein Expression and Purification 139, pages 57-62.
Crossref
Crossref
Reeta Rai, Sameer Dubey, K.V. Santosh, Ashutosh Biswas, Vinit Mehrotra & D.N. Rao. (2017) Design and synthesis of multiple antigenic peptides and their application for dengue diagnosis. Biologicals 49, pages 81-85.
Crossref
Crossref
Nattika Nantachit, Panya Sunintaboon & Sukathida Ubol. (2017)
EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an
in vitro
model
. Microbiology and Immunology 61:8, pages 305-317.
Crossref
Crossref
Matthew H. Collins & Stefan W. Metz. (2017) Progress and Works in Progress: Update on Flavivirus Vaccine Development. Clinical Therapeutics 39:8, pages 1519-1536.
Crossref
Crossref
Maxime Combe, Xavier Lacoux, Jérôme Martinez, Odile Méjan, Françoise Luciani & Soizic Daniel. (2017) Expression, refolding and bio-structural analysis of a tetravalent recombinant dengue envelope domain III protein for serological diagnosis. Protein Expression and Purification 133, pages 57-65.
Crossref
Crossref
Nagesh K Tripathi & Ambuj Shrivastava. (2017) Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2. AIMS Microbiology 3:2, pages 248-266.
Crossref
Crossref
Nattika Nantachit, Panya Sunintaboon & Sukathida Ubol. (2016) Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination. Virology Journal 13:1.
Crossref
Crossref
Anna S. Ershova, Olga A. Gra, Alexander M. Lyaschuk, Tatyana M. Grunina, Artem P. Tkachuk, Mikhail S. Bartov, Darya M. Savina, Olga V. Sergienko, Zoya M. Galushkina, Vladimir P. Gudov, Liubov I. Kozlovskaya, Ivan S. Kholodilov, Larissa V. Gmyl, Galina G. Karganova, Vladimir G. Lunin, Anna S. Karyagina & Alexander L. Gintsburg. (2016) Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice. BMC Infectious Diseases 16:1.
Crossref
Crossref
Mi-Young Kim, Byeong-Young Kim & Moon-Sik Yang. (2016) Synthesis and assembly of dengue virus envelope protein fused to cholera toxin B subunit into biologically active oligomers in transgenic tomato (Solanum lycopersicum). Plant Biotechnology Reports 10:4, pages 219-226.
Crossref
Crossref
Johanna Gottschamel, Andreas Lössl, Stephanie Ruf, Yanliang Wang, Morten Skaugen, Ralph Bock & Jihong Liu Clarke. (2016) Production of dengue virus envelope protein domain III-based antigens in tobacco chloroplasts using inducible and constitutive expression systems. Plant Molecular Biology 91:4-5, pages 497-512.
Crossref
Crossref
Sean P. McBurney, Justine E. Sunshine, Sarah Gabriel, Jeremy P. Huynh, William F. Sutton, Deborah H. Fuller, Nancy L. Haigwood & William B. Messer. (2016) Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine 34:30, pages 3500-3507.
Crossref
Crossref
Chen-Yi Chiang, Shih-Jen Liu, Chun-Hsiang Hsieh, Mei-Yu Chen, Jy-Ping Tsai, Hsueh-Hung Liu, I.-Hua Chen, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2016) Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice. Vaccine 34:8, pages 1054-1061.
Crossref
Crossref
Niyati Khetarpal & Ira Khanna. (2016) Dengue Fever: Causes, Complications, and Vaccine Strategies. Journal of Immunology Research 2016, pages 1-14.
Crossref
Crossref
Nagesh K. Tripathi, Karttik C. Biswal & P. V. Lakshmana Rao. (2015)
Scaling Up of Recombinant Dengue Virus Type 3 Envelope Domain III Protein Production from
Escherichia coli
. Industrial Biotechnology 11:6, pages 331-337.
Crossref
Crossref
Berlin Londono-Renteria, Andrea Troupin, Michael J Conway, Diana Vesely, Michael Ledizet, Christopher M. Roundy, Erin Cloherty, Samuel Jameson, Dana Vanlandingham, Stephen Higgs, Erol Fikrig & Tonya M. Colpitts. (2015) Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein. PLOS Pathogens 11:10, pages e1005202.
Crossref
Crossref
Ge Liu, Langzhou Song, David W. C. Beasley, Robert Putnak, Jason Parent, John Misczak, Hong Li, Lucia Reiserova, Xiangyu Liu, Haijun Tian, Wenzhe Liu, Darlene Labonte, Lihua Duan, Youngsun Kim, Linda Travalent, Devin Wigington, Bruce Weaver & Lynda Tussey. (2015) Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys. Clinical and Vaccine Immunology 22:5, pages 516-525.
Crossref
Crossref
Guoyu Niu, Zheng Pang, Chun Guan, Jun Qi & Dexin Li. (2015) Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis. Virus Research 201, pages 73-78.
Crossref
Crossref
Eugenia Li Ling Yeo, Anthony Jin Shun Chua, Krupakar Parthasarathy, Hui Yu Yeo, Mah Lee Ng & James Chen Yong Kah. (2015) Understanding aggregation-based assays: nature of protein corona and number of epitopes on antigen matters. RSC Advances 5:20, pages 14982-14993.
Crossref
Crossref
Vivian Huerta, Patricia Toledo, Noralvis Fleitas, Alejandro Martín, Dianne Pupo, Alexis Yero, Mónica Sarría, Aniel Sánchez, Vladimir Besada, Yassel Ramos, Gabriel Márquez, Osmany Guirola & Glay Chinea. (2014) Receptor-activated human α2-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through multivalent binding. Journal of General Virology 95:12, pages 2668-2676.
Crossref
Crossref
Alienys Izquierdo, Angélica García, Laura Lazo, Lázaro Gil, Ernesto Marcos, Mayling Alvarez, Iris Valdés, Lisset Hermida, Gerardo Guillén & María G. Guzmán. (2014) A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice. Archives of Virology 159:10, pages 2597-2604.
Crossref
Crossref
Raissa Prado Rocha, Márcia Cristina Livonesi, Marcilio Jorge Fumagalli, Naiara Ferreira Rodrigues, Lauro César Felipe da Costa, Michelle Cristina Silva Gomes dos Santos, Eliseu Soares de Oliveira Rocha, Erna Geessien Kroon, Luiz Cosme Cotta Malaquias & Luiz Felipe Leomil Coelho. (2014) Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II. Virus Research 188, pages 122-127.
Crossref
Crossref
Olesia Lisova, Laurent Belkadi & Hugues Bedouelle. (2014) Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus. Journal of Molecular Recognition 27:4, pages 205-214.
Crossref
Crossref
Chen-Yi Chiang, Chun-Hsiang Hsieh, Mei-Yu Chen, Jy-Ping Tsai, Hsueh-Hung Liu, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2014) Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity. Vaccine 32:12, pages 1346-1353.
Crossref
Crossref
Fithriyah Sjatha, Miwa Kuwahara, T. Mirawati Sudiro, Masanori Kameoka & Eiji Konishi. (2014) Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response. Microbiology and Immunology 58:2, pages 126-134.
Crossref
Crossref
Hui Zhao, Tao Jiang, Xi-Zhen Zhou, Yong-Qiang Deng, Xiao-Feng Li, Shui-Ping Chen, Shun-Ya Zhu, Xi Zhou, E-De Qin & Cheng-Feng Qin. (2014) Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine. PLoS ONE 9:1, pages e86573.
Crossref
Crossref
Kaiting Ng & John E. Connolly. 2014. Dengue. Dengue
53
74
.
Nora Zidane, Philippe Dussart, Laetitia Bremand & Hugues Bedouelle. (2013) Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins. BMC Infectious Diseases 13:1.
Crossref
Crossref
Chen-Yi Chiang, Chien-Hsiung Pan, Chun-Hsiang Hsieh, Jy-Ping Tsai, Mei-Yu Chen, Hsueh-Hung Liu, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2013) Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement. PLoS Neglected Tropical Diseases 7:9, pages e2432.
Crossref
Crossref
Chen-Yi Chiang, Ming-Hsi Huang, Chien-Hsiung Pan, Chun-Hsiang Hsieh, Mei-Yu Chen, Hsueh-Hung Liu, Jy-Ping Tsai, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2013) Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III. Microbes and Infection 15:10-11, pages 719-728.
Crossref
Crossref
Sophie Yacoub, Juthathip Mongkolsapaya & Gavin Screaton. (2013) The pathogenesis of dengue. Current Opinion in Infectious Diseases 26:3, pages 284-289.
Crossref
Crossref
N. Zidane, P. Dussart, L. Bremand, M. E. Villani & H. Bedouelle. (2013) Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design. Protein Engineering Design and Selection 26:6, pages 389-399.
Crossref
Crossref
Nancy Coconi-Linares, Enrique Ortega-Dávila, Moisés López-González, Jazmín García-Machorro, Julio García-Cordero, Ralph M. Steinman, Leticia Cedillo-Barrón & Miguel A. Gómez-Lim. (2013) Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice. Vaccine 31:19, pages 2366-2371.
Crossref
Crossref
Mi-Young Kim, Nguyen-Duc Chung, Moon-Sik Yang & Tae-Geum Kim. (2012) Expression of a cholera toxin B subunit and consensus dengue virus envelope protein domain III fusion gene in transgenic rice callus. Plant Cell, Tissue and Organ Culture (PCTOC) 112:3, pages 311-320.
Crossref
Crossref
Rosmari Rodriguez-Roche & Ernest A. Gould. (2013) Understanding the Dengue Viruses and Progress towards Their Control. BioMed Research International 2013, pages 1-20.
Crossref
Crossref
Upasana Arora, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2013) Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 31:6, pages 873-878.
Crossref
Crossref
Upasana Arora, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2012) Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. Journal of Nanobiotechnology 10:1.
Crossref
Crossref
Reshma Kulkarni, Gajanan Sapkal & Milind Gore. (2012) Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice. Virus Research 170:1-2, pages 118-125.
Crossref
Crossref
C.A. Martínez, A.M. Giulietti & J. Rodríguez Talou. (2012) Research advances in plant-made flavivirus antigens. Biotechnology Advances 30:6, pages 1493-1505.
Crossref
Crossref
David M. Bowen, Jessica A. Lewis, Wenzhe Lu & Catherine H. Schein. (2012) Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes. Vaccine 30:42, pages 6081-6087.
Crossref
Crossref
Alienys Izquierdo, Iris Valdés, Lázaro Gil, Lisset Hermida, Sheila Gutiérrez, Angélica García, Lidice Bernardo, Alekis Pavón, Gerardo Guillén & María G. Guzmán. (2012) Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2. Antiviral Research 95:1, pages 1-8.
Crossref
Crossref
Chen-Yi Chiang, Ming-Hsi Huang, Chun-Hsiang Hsieh, Mei-Yu Chen, Hsueh-Hung Liu, Jy-Ping Tsai, Yi-Shiuan Li, Ching-Yun Chang, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2012) Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses. PLoS Neglected Tropical Diseases 6:5, pages e1645.
Crossref
Crossref
Lisset Hermida, Iris Valdés, Lázaro Gil, Lídice Bernardo, Laura Lazo, Yaremis Romero, María G. Guzmán & Gerardo Guillén. (2012) The serogroup A capsular polysaccharide from Neisseria meningitidis enhances the cell-mediated immunity and the protective capacity induced by a dengue fusion protein in mice. Archives of Virology 157:5, pages 987-991.
Crossref
Crossref
Wahala M. P. B. Wahala, Claire Huang, Siritorn Butrapet, Laura J. White & Aravinda M. de Silva. (2012) Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera. Journal of Virology 86:7, pages 4019-4023.
Crossref
Crossref
Van-Mai Cao-Lormeau, Claudine Roche, Maite Aubry, Anita Teissier, Stéphane Lastere, Elise Daudens, Henri-Pierre Mallet, Didier Musso & John Aaskov. (2011) Recent Emergence of Dengue Virus Serotype 4 in French Polynesia Results from Multiple Introductions from Other South Pacific Islands. PLoS ONE 6:12, pages e29555.
Crossref
Crossref
Gaurav Batra, Satish K Nemani, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2011) Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera. BMC Infectious Diseases 11:1.
Crossref
Crossref
Chen-Yi Chiang, Shih-Jen Liu, Jy-Ping Tsai, Yi-Shiuan Li, Mei-Yu Chen, Hsueh-Hung Liu, Pele Chong, Chih-Hsiang Leng & Hsin-Wei Chen. (2011) A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses. PLoS ONE 6:8, pages e23319.
Crossref
Crossref
Shanfeng Li, Liang Peng, Wei Zhao, Hua Zhong, Fuchun Zhang, Ziqiang Yan & Hong Cao. (2011) Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses. Vaccine 29:20, pages 3695-3702.
Crossref
Crossref
Nagesh K. Tripathi, Ambuj Shrivastava, Karttik C. Biswal & P. V. Lakshmana Rao. (2011) Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli. Biotechnology Journal 6:5, pages 604-608.
Crossref
Crossref
Juergen Zlatkovic, Karin Stiasny & Franz X. Heinz. (2011) Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in Mice. Journal of Virology 85:5, pages 1994-2003.
Crossref
Crossref
Lik Chern Melvin Tan, Anthony Jin Shun Chua, Li Shan Liza Goh, Shu Min Pua, Yuen Kuen Cheong & Mah Lee Ng. (2010) Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography. Protein Expression and Purification 74:1, pages 129-137.
Crossref
Crossref
Sofia Lizeth Alcaraz-Estrada, Martha Yocupicio-Monroy & Rosa María del Angel. (2010) Insights into dengue virus genome replication. Future Virology 5:5, pages 575-592.
Crossref
Crossref
Gaurav Batra, Rajendra Raut, Satinder Dahiya, Neha Kamran, Sathyamangalam Swaminathan & Navin Khanna. (2010) Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies. Journal of Virological Methods 167:1, pages 10-16.
Crossref
Crossref